Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
McKinsey
McKesson
Colorcon
Express Scripts

Last Updated: January 26, 2023

CLINICAL TRIALS PROFILE FOR DEXMETHYLPHENIDATE HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


All Clinical Trials for Dexmethylphenidate Hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00047476 ↗ D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients Completed Celgene Corporation Phase 2 2002-06-01 To evaluate the efficacy of dexmethylphenidate (d-MPH) in the treatment of chemotherapy-related fatigue in adult cancer subjects.
NCT00141050 ↗ Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD Completed Novartis Phase 3 2005-05-01 The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.
NCT00141063 ↗ Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD Completed Novartis Phase 3 2005-06-01 The purpose of this study is to compare the safety and efficacy of two doses of dexmethylphenidate to two doses of an approved, long-acting, marketed medication for ADHD (MPH) and placebo in children ages 6-12 diagnosed with ADHD.
NCT00301236 ↗ Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder Completed Novartis Phase 3 2006-02-01 The purpose of this study is to determine which dosages of dexmethylphenidate HCl extended-release capsules may represent effective treatment for ADHD in children 6-12 years of age.
NCT00361387 ↗ Use of Focalin for Fatigue in Sarcoidosis Completed University of Cincinnati Phase 4 2006-06-01 Patients diagnosed with chronic sarcoidosis with fatigue for more than 6 months. Sarcoidosis and its treatment can greatly affect your quality of life. Many patients suffer from fatigue (feeling tired), lack of focus and concentration, in ability to organize their daily activities, and memory loss. These commonly reported symptoms often get in the way of everyday life.
NCT00393042 ↗ Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR Completed Novartis Phase 3 2006-01-01 The purpose of this study is to evaluate how children and adolescents with Attention Deficit/ Hyperactivity Disorder (ADHD) respond to treatment with three differing doses of stimulant medications used to treat ADHD, Adderall XR® and Focalin XR®. Another purpose of the study is to evaluate if there are differences in sleep and other side effects, such as changes in mood or loss of appetite, which can occur with stimulant medications. A third purpose is to determine if there are differences in the characteristics of individuals who respond better to either of the medications. This research is being done because the investigators do not know if one of these two commonly used treatments is better tolerated than the other. Children and adolescents with ADHD often have a hard time sitting still, playing quietly, finishing things they start, paying attention, waiting their turn, and not distracting others. These medications improve these symptoms, but sometimes affect sleep, appetite, or mood. It is hypothesized that at effective and frequently prescribed doses, Adderall will be associated with insomnia, more stimulant side effects, and decreased tolerability during an acute trial relative to Focalin.
NCT00393042 ↗ Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR Completed Seattle Children's Hospital Phase 3 2006-01-01 The purpose of this study is to evaluate how children and adolescents with Attention Deficit/ Hyperactivity Disorder (ADHD) respond to treatment with three differing doses of stimulant medications used to treat ADHD, Adderall XR® and Focalin XR®. Another purpose of the study is to evaluate if there are differences in sleep and other side effects, such as changes in mood or loss of appetite, which can occur with stimulant medications. A third purpose is to determine if there are differences in the characteristics of individuals who respond better to either of the medications. This research is being done because the investigators do not know if one of these two commonly used treatments is better tolerated than the other. Children and adolescents with ADHD often have a hard time sitting still, playing quietly, finishing things they start, paying attention, waiting their turn, and not distracting others. These medications improve these symptoms, but sometimes affect sleep, appetite, or mood. It is hypothesized that at effective and frequently prescribed doses, Adderall will be associated with insomnia, more stimulant side effects, and decreased tolerability during an acute trial relative to Focalin.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Dexmethylphenidate Hydrochloride

Condition Name

Condition Name for Dexmethylphenidate Hydrochloride
Intervention Trials
ADHD 5
Attention Deficit Hyperactivity Disorder 3
Sarcoidosis 2
Attention Deficit Hyperactivity Disorder Combined 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Dexmethylphenidate Hydrochloride
Intervention Trials
Attention Deficit Disorder with Hyperactivity 5
Hyperkinesis 3
Fatigue 3
Disease 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Dexmethylphenidate Hydrochloride

Trials by Country

Trials by Country for Dexmethylphenidate Hydrochloride
Location Trials
United States 38
United Kingdom 1
Brazil 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Dexmethylphenidate Hydrochloride
Location Trials
Kansas 3
New York 2
Missouri 2
Arizona 2
California 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Dexmethylphenidate Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Dexmethylphenidate Hydrochloride
Clinical Trial Phase Trials
Phase 4 2
Phase 3 6
Phase 2 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Dexmethylphenidate Hydrochloride
Clinical Trial Phase Trials
Completed 11
Not yet recruiting 3
Recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Dexmethylphenidate Hydrochloride

Sponsor Name

Sponsor Name for Dexmethylphenidate Hydrochloride
Sponsor Trials
Novartis 4
Cingulate Therapeutics 4
Rho, Inc. 2
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Dexmethylphenidate Hydrochloride
Sponsor Trials
Industry 15
Other 8
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Dow
McKesson
Moodys
AstraZeneca
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.